Today's Spotlight

Look Out for Iatrogenic Dry Eye

A notable addition to TFOS DEWS II is a report on iatrogenic dry eye. Not a subject covered in the original DEWS report, it was time to acknowledge “the number of cases of dry eye that are caused by medical examination or treatment such as topical medications, systemic drugs, ophthalmic surgical procedures and even cosmetic procedures,” says James S. Wolffsohn, PhD, a member of the DEWS II iatrogenic subcommittee and harmonizer for the report. This article discusses the new findings in iatrogenic dry eye and how you can use them to better serve your patients.
Today's Spotlight

Breaking the Burden: A New Way to Deliver Anti-VEGF

Anti-vascular endothelial growth factor (VEGF) therapy has dramatically revolutionized the management of age-related macular degeneration (AMD), diabetic macular edema and retinal vein occlusions. Many trials have shown that, worldwide, the treatment has significantly changed outcomes in patients with retinal vascular disease and reduced the incidence of blindness from these conditions. In each of these indications, the best outcomes have been shown with fixed dosing schedules. However, such a regimen risks either over- or undertreatment if the chosen intervals between treatments are too short or too long.

New technologies that could extend the duration between treatments could offer a significant benefit to patients by reducing the burden of treatment while improving vision. 
Today's Spotlight

News

More than a year after proposing changes to the Contact Lens Rule, the Federal Trade Commission is answering pushback from the American Optometric Association (AOA), lawmakers, practitioners and other advocates with a public Contact Lens Rule Workshop on March 7 in Washington, DC. The gathering, designed to discuss contact lens marketplace competition, consumer access, prescription release and portability, and other contact lens-related subjects, will feature panelists, public comments and feedback.

A persistent advocate for contact lens patient health and safety, the AOA says it will be an active participant in the upcoming workshop.
Today's Spotlight

AI for DR: “The Digital Doctor Will See You Now”

The ability to design technology that can mimic some elements of human cognition, once purely the stuff of science fiction, is becoming a reality. Medicine generally and eye care specifically are among the facets of daily life that stand to be transformed by this technology, allowing doctors to become more accessible and efficient. The successful optometric practice of the future will be one that chooses to see artificial intelligence not as a threat but rather as a tool to enhance uniquely human skills such as intuition and insight that are the hallmark of a good doctor.
Today's Spotlight

News Review

Patients with rare eye conditions such as neovascular inflammatory vitreoretinopathy (NIV) often have limited therapeutic options, especially when conventional treatments fail. But researchers at the Stanford University School of Medicine are looking to change that with precision medicine. They turned to proteomics to better identify molecular pathways in NIV pathologies—and available potential targets for therapy.
Feb 22
Feb 21
Feb 20
Feb 19
Feb 18

Look Inside The Current Issue

February 15, 2018

Features

AI for DR: “The Digital Doctor Will See You Now”

Software that can detect ocular anomalies may offer new ways to reduce the loss of vision due to diabetic retinopathy.

Breaking the Burden: A New Way to Deliver Anti-VEGF

An implantable drug reservoir looks to shake up today’s successful but untenable protocols.

How the Diploma Deluge is Reshaping Optometry

The student population is booming, but applicants haven’t kept pace. Here are three ways to protect academic standards and avoid a glut.

Myopia Management in Action

These clinical pearls can help you establish a successful subspecialty within your practice.

Prospects for Neuroprotection in Glaucoma

Investigators are gunning for glaucoma. Here, one shares some thoughts from the frontlines.

Rethinking Endothelial Repair

An eye drop that might regrow cells and a graft-free surgical technique may soon revolutionize the treatment regimen for these patients.

Thyroid Disease: A Delicate Balance Disrupted

This diagnosis isn’t as cut-and-dry as you think; be prepared to manage both hyper- and hypothyroid patients.

Departments

25 Ways to Win the Temp Wars

Private practice optometry runs hot and cold—and I’m not talking about the business side of things.

A Bad Break-up

When the vitreous and retina don’t separate fully, macular traction can be problematic—or benign. How, and when, to manage?

A Giant Problem Overlooked

Don’t always attribute new patient complaints to age—especially if it could be giant cell arteritis.

Don’t Stress

Endothelial blebs be a sign of a problematic scleral lens fit. Here’s what you should do to avoid them.

Foretold in the Stars

How do this patient’s comorbidities inform your diagnosis?

Glaucoma’s New Foe, Explained

How a recently approved formulation aims to improve pressure control.

Hone Your Astigmatic Refraction

Use these tips to refine your skills and perform this task more swiftly.

Letters to the Editor

"We must, as a profession, start speaking about low vision to all AMD patients."

Lumps and Bumps Be Gone

Shave excision can be a simple answer to your patient’s eyelid margin lesion.

News Review

Precision Eye Care | AMD | 2018 Conference Schedule

Product Review

Contact Lenses | Diagnostic Technology

Reinventing Optometry Every Day

One thing we can count on is continuous, rapid change—and our profession is no exception.

She’s on a Losing Streak

A 52-year-old white female presented to the office with a chief complaint of blurry vision in both eyes at distance and near.

The Coding is in the Details

Using new technologies to screen for early disease can be great for patient care—as long as you use them wisely.

The Stars of Tomorrow

We shine a light on several new ideas that might change clinical practice. Will they flourish—or flop?

Two Conditions, One Implant

Non-medical options may be more appropriate when glaucoma patients also have ocular surface disease.

Where’s the Degeneration?

A significant case of subretinal hemorrhaging leads one OD to a rare disease.

E-Newsletters

Practice Pearls

Expert clinician Paul Karpecki, OD, provides practical insights and management strategies for a wide array of ocular conditions.

RCCL e-News

A quick read of the best pearls from the current issue of Review of Cornea & Contact Lenses, with links to full articles.

Optometric Retina Society E-Newsletter

Keep up to date on the latest research and clinical findings in retinal disease care with this quarterly publication from the ORS.

Optometric Physician E-Journal

A weekly e-journal edited by Art Epstein, OD, featuring incisive commentary, timely research summaries and late-breaking news.

Jobs

Jobs Powered By Local Eye Site

Review of Cornea & Contact Lenses

Jan/Feb 2018

Women in Optometry

Women in Optometry - November 2017